Adia Med, Inc. (ADIA) stock

ADIAOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.13−0.01 (-7.14%)

Close on Oct 19, 2026Market cap $20.98MP/E –Yield –

Adia Med total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Adia Med has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADIA.

Revenue growth10879.7% · median 4.2%

Gross margin27.4% · median 66.4%

Operating margin-52.3% · median -2180.9%

Net margin-56.5% · median -1932.8%

Advertisement
300 × 250

See a number that looks wrong?